Logo image
On-demand biomanufacturing of protective conjugate vaccines
Journal article   Open access   Peer reviewed

On-demand biomanufacturing of protective conjugate vaccines

Jessica C Stark, Thapakorn Jaroentomeechai, Tyler D Moeller, Jasmine M Hershewe, Katherine F Warfel, Bridget S Moricz, Anthony M Martini, Rachel S Dubner, Karen J Hsu, Taylor C Stevenson, …
Science advances, Vol.7(6), eabe9444
02/2021
DOI: 10.1126/sciadv.abe9444
PMCID: PMC7857678
PMID: 33536221
url
https://doi.org/10.1126/sciadv.abe9444View
Published (Version of record) Open Access

Abstract

Conjugate vaccines are among the most effective methods for preventing bacterial infections. However, existing manufacturing approaches limit access to conjugate vaccines due to centralized production and cold chain distribution requirements. To address these limitations, we developed a modular technology for in vitro conjugate vaccine expression (iVAX) in portable, freeze-dried lysates from detoxified, nonpathogenic Upon rehydration, iVAX reactions synthesize clinically relevant doses of conjugate vaccines against diverse bacterial pathogens in 1 hour. We show that iVAX-synthesized vaccines against subsp. (type A) strain Schu S4 protected mice from lethal intranasal challenge. The iVAX platform promises to accelerate development of new conjugate vaccines with increased access through refrigeration-independent distribution and portable production.

Details

Metrics

Logo image